Galenika Medical Journal,
Journal Year:
2024,
Volume and Issue:
3(9), P. 49 - 52
Published: Jan. 1, 2024
Primary
(essential)
hypertension
includes
about
90%
of
all
cases
hypertension,
and
the
treatment
is
symptomatic.
As
response
to
need
for
suppression
sympathetic
activity
in
regulation
central
antihypertensives
have
been
developed,
through
peripheral
adrenergic
non-adrenergic
mechanisms,
affect
reduction
nerve
activity,
inhibition
norepinephrine
release,
systemic
vascular
resistance,
vasodilatation,
heart
rate
lowering
blood
pressure.
Moxonidine
has
proven
be
effective
safe,
whether
used
as
monotherapy
or
combination
which
hyperactivity
predominates,
especially
patients
with
metabolic
syndrome,
obese
patients,
prehypertension
stress
induced
catecholamine
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 901 - 901
Published: Jan. 11, 2024
Thoracic
aortic
aneurysm
(TAA)
has
a
prevalence
of
0.16–0.34%
and
an
incidence
7.6
per
100,000
person-years,
accounting
for
1–2%
all
deaths
in
Western
countries.
Currently,
no
effective
pharmacological
therapies
have
been
identified
to
slow
TAA
development
prevent
rupture.
Large
TAAs
are
treated
with
open
surgical
repair
less
invasive
thoracic
endovascular
repair,
both
which
high
perioperative
mortality
risk.
Therefore,
there
is
urgent
medical
need
identify
the
cellular
molecular
mechanisms
underlying
rupture
develop
new
therapies.
In
this
review,
we
summarize
animal
models
including
recent
developments
porcine
zebrafish
models:
can
assess
therapeutic
devices
or
intervention
strategies
large
mammal
employ
large-scale
small-molecule
suppressor
screening
microwells.
The
second
part
review
covers
current
views
pathogenesis,
derived
from
studies
using
these
models,
focus
on
roles
transforming
growth
factor-beta
(TGFβ)
pathway
vascular
smooth
muscle
cell
(VSMC)-elastin-contractile
unit.
last
discusses
treatment
options
as
they
emerge
preclinical
studies.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(17), P. 13132 - 13132
Published: Aug. 23, 2023
Atherosclerosis
is
characterized
by
the
narrowing
of
arterial
lumen
due
to
subendothelial
lipid
accumulation,
with
hypercholesterolemia
being
a
major
risk
factor.
Despite
recent
advances
in
effective
lipid-lowering
therapies,
atherosclerosis
remains
leading
cause
mortality
globally,
highlighting
need
for
additional
therapeutic
strategies.
Accumulating
evidence
suggests
that
sympathetic
nervous
system
plays
an
important
role
atherosclerosis.
In
this
article,
we
reviewed
innervation
vasculature,
norepinephrine
synthesis
and
metabolism,
activity
measurement,
common
signaling
pathways
activation.
The
focus
paper
was
review
effectiveness
pharmacological
antagonists
or
agonists
adrenoceptors
(α1,
α2,
β1,
β2,
β3)
renal
denervation
on
All
five
types
are
present
blood
vessels.
α1
blockers
inhibit
but
increase
heart
failure
while
α2
agonism
may
protect
against
newer
generations
β
β3
promising
therapies
atherosclerosis;
however,
new
randomized
controlled
trials
warranted
investigate
these
inhibition
cardiovascular
reduction
future.
humans
yet
be
established.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2553 - 2553
Published: March 12, 2025
Sympathetic
nerves
innervate
bone
marrow
and
various
immune
organs,
where
norepinephrine—the
primary
sympathetic
neurotransmitter—directly
interacts
with
cells
that
express
adrenergic
receptors.
This
article
reviewed
the
key
molecular
pathways
triggered
by
activation
explored
how
activity
influences
cell
migration.
Norepinephrine
serves
as
a
chemoattractant
for
monocytes,
macrophages,
stem
cells,
promoting
migration
of
myeloid
while
inhibiting
lymphocytes
at
physiological
concentrations.
We
also
examined
role
infiltration
in
cardiovascular
diseases
cancer.
Evidence
suggests
increases
into
target
tissues
across
diseases,
including
atherosclerosis,
hypertension,
cardiac
fibrosis,
hypertrophy,
arrhythmia,
myocardial
infarction,
heart
failure,
stroke.
Conversely,
may
serve
potential
therapeutic
strategy
to
treat
these
conditions
reducing
macrophage
infiltration.
Furthermore,
promotes
accumulation
cancer
tissues,
mirroring
its
effects
suppressing
T
lymphocyte
cancerous
sites.
These
changes
contribute
increased
growth
metastasis.
Thus,
could
help
protect
against
enhancing
presence
tumors.
The FASEB Journal,
Journal Year:
2025,
Volume and Issue:
39(9)
Published: April 30, 2025
ABSTRACT
Chronic
psychological
stress
(CPS)
is
a
significant
risk
factor
for
thrombotic
cardio‐cerebrovascular
diseases
(TCVDs).
Clinical
data
suggest
that
the
α
2
‐adrenergic
receptor
(AdR‐α
)
agonist
dexmedetomidine
(Dex)
can
influence
coagulation
in
stress‐exposed
intensive
care
unit
patients.
Given
important
role
of
protease‐activated
receptor‐2
(PAR‐2)
vascular
pathobiology,
we
aimed
to
investigate
potential
effects
Dex
on
stress‐related
thrombus
formation,
focusing
PAR‐2
signaling
pathway.
Eight‐week‐old
male
mice
underwent
non‐stress
and
immobilization
with
treatment
weeks
were
then
subjected
carotid
artery
thrombosis
induction
using
ferric
chloride
(FeCl
3
).
On
Day
14
post‐stress,
exhibited
increased
weight
length,
along
harmful
alterations
plasma
levels
von
Willebrand
metalloproteinase
thrombospondin
Type
13
motifs.
Additionally,
arterial
protein
and/or
mRNA
PAR‐2,
p‐Akt,
Bcl‐2,
cleaved
caspase‐3,
cytochrome
c
,
gp91
phox
TNF‐α,
MCP‐1,
ICAM‐1,
VCAM‐1,
TLR‐4
altered,
accompanied
by
endothelial
loss.
reversed
these
changes.
Conversely,
AdR‐α2
blockage
yohimbine
diminished
benefits
Dex.
In
vitro,
reduced
serum‐induced
reactive
oxygen
species
production
apoptosis,
beneficial
levels.
Yohimbine
effects.
Thus,
activation
appeared
mitigate
formation
undergoing
FeCl
‐induced
surgery,
possibly
negatively
regulating
signaling.
These
findings
therapeutic
strategy
CPS‐related
events
patients
TCVDs.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(21), P. 15955 - 15955
Published: Nov. 3, 2023
The
rupture
of
an
abdominal
aortic
aneurysm
(AAA)
causes
about
200,000
deaths
worldwide
each
year.
However,
there
are
currently
no
effective
drug
therapies
to
prevent
AAA
formation
or,
when
present,
decrease
progression
and
rupture,
highlighting
urgent
need
for
more
research
in
this
field.
Increased
vascular
inflammation
enhanced
apoptosis
smooth
muscle
cells
(VSMCs)
implicated
formation.
Here,
we
investigated
whether
hydralazine,
which
has
anti-inflammatory
anti-apoptotic
properties,
inhibited
pathological
hallmarks.
In
cultured
VSMCs,
hydralazine
(100
μM)
the
increase
inflammatory
gene
expression
induced
by
acrolein
hydrogen
peroxide,
two
oxidants
that
may
play
a
role
pathogenesis.
effect
was
associated
with
caspase
8
expression.
mouse
model
subcutaneous
angiotensin
II
infusion
(1
µg/kg
body
weight/min)
28
days
apolipoprotein
E-deficient
mice,
treatment
(24
mg/kg/day)
significantly
decreased
incidence
from
80%
20%
suprarenal
diameter
32%
2.26
mm
1.53
mm.
Hydralazine
also
increased
survival
rate
60%
100%.
conclusion,
model,
its
properties.
Age-related
pathologies,
particularly
cardiovascular
disorders,
pose
a
significant
global
health
concern.
The
World
Health
Organization
(WHO)
predicts
an
increase
in
advanced
mortality
by
2030
unless
critical
interventions
are
implemented.
Atherosclerosis
remains
the
major
cause
of
various
diseases.
Hence,
this
review
focused
on
interaction
between
known
mechanisms
vascular
aging,
disease
manifestation,
and
progression
during
atherosclerosis.
In
review,
we
highlighted
five
altered
models:
genomic
instability,
neurohormonal
deregulation,
epigenetics,
protein
regulation,
gut
microbiome.
articles
were
selected
from
indexed
scientific
databases.
It
is
important
to
note
that
equally
interrelated
with
other
aging
pathways,
such
as
inflammation
senescence.
conclusion,
atherosclerosis
multifaceted
cholesterol-lowering
therapy
has
been
widely
used.
However,
more
than
one
specific
action
line
required
eradicate
or
slow
down
its
manifestation.
Equally,
establishing
balance
stressors
resulting
injuries
stress
buffering
treatment
promising
therapeutic
targets
reviewed
include
angiotensin
(1–7)/MAS
axis,
microbiome,
histone
deacetylases,
DNA
repair
systems,
noncoding
RNAs,
β3/dopamine
adrenoceptors,
senescence
checkpoints.
Frontiers in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 14, 2024
Objective
The
present
study
aimed
at
evaluating
the
association
between
sympathetic
nervous
system
activation
(SNS)
and
severity
of
coronary
artery
disease
(CAD).
In
addition,
we
tested
hypothesis
that
inflammation
oxidative
stress
influence
SNS
activation.
Methods
Adult
patients
with
severe
CAD
scheduled
for
bypass
graft
(CABG)
surgery
were
enrolled.
SYNTAX
I
score
was
calculated
based
on
angiography.
Systemic
estimated
through
circulating
levels
norepinephrine
(NE).
Plasma
pro-inflammatory
cytokines
(IL
1β,
IL
6
HIF
1α)
molecules
(SOD-1
LOX-1)
obtained
prior
to
surgery.
Results
Circulating
NE
significantly
correlated
CAD,
as
assessed
by
(
p
0.002;
r
0.329).
Elevated
markers
increased
concentrations
(for
IL-1β:
<
0.001,
=
0.49;
IL-6
NE:
0.003,
0.32;
HIF-1α
0.049,
0.21).
Additionally,
associated
SOD-1
0.016,
0.26;
LOX-1
0.004,
0.31).
Conclusion
referred
CABG,
activation,
indicated
plasma
levels,
score,
well
stress.
This
suggests
inflammation,
stress,
form
an
interconnected
network,
each
component
influencing
others.
It
might
be
interest
develop
a
scoring
including
identify
require
more
aggressive
approach
lower
modulate
system.
could
use
especially
in
setting
intervention
-such
CABG
Processes,
Journal Year:
2023,
Volume and Issue:
11(6), P. 1738 - 1738
Published: June 7, 2023
The
stability
of
active
pharmaceutical
ingredients
(APIs)
and
the
corresponding
formulations
are
nowadays
great
importance
in
research
technology.
quality
an
API
or
finished
products
(FPPs)
is
time
dependent
under
influence
several
parameters,
such
as
light
air
exposure,
temperature,
humidity.
Additionally,
profile
influenced
by
formulation
composition,
due
to
presence
excipients
characteristic
packaging
materials.
In
this
sense,
main
objective
study
was
analyze
degradation
kinetics
antihypertensive
drug
moxonidine
a
pure
ingredient
(MOX)
two
different
solid
mixtures,
one
(MOXTAB)
other
enriched
MOX
(MOXMIX).
As
investigation
techniques,
FTIR
(Fourier
transform
infrared)
spectroscopy
TG/DTG/HF
analysis
were
employed,
while
thermoanalytical
data
processed
according
ASTM
E698
kinetic
method
isoconversional
methods
Flynn–Wall–Ozawa
(FWO)
Friedman
(FR).
revealed
that
have
stabilizing
effect
on
(in
terms
Ea
values),
but
decomposition
mechanism
samples
complex,
results
suggested
vs.
α
values.
Thoracic
aortic
aneurysm
(TAA)
has
a
prevalence
of
0.16%-0.34%
and
an
incidence
7.6
per
100,000
person-years,
accounting
for
1%-2%
all
deaths
in
Western
countries.
Currently,
no
effective
pharmacological
therapies
have
been
identified
to
slow
TAA
development
prevent
rupture.
Large
TAAs
are
treated
with
open
surgical
repair
less
invasive
thoracic
endovascular
repair,
both
which
high
perioperative
mortality
risk.
Therefore,
there
is
urgent
medical
need
identify
the
cellular
molecular
mechanisms
underlying
rupture
develop
new
therapies.
In
this
review,
we
summarize
animal
models
including
recent
developments
porcine
zebrafish
models:
can
assess
therapeutic
devices
or
intervention
strategies
large
mammal
employ
large-scale
small-molecule
suppressor
screening
microwells.
The
second
part
review
covers
current
views
pathogenesis,
focus
on
roles
transforming
growth
factor-beta
(TGFβ)
pathway
vascular
smooth
muscle
cell
(VSMC)-elastin-contractile
unit.
last
discusses
treatment
options
as
they
emerge
from
preclinical
studies.